Skip to main content

Table 2 Sensitivities and specificities at the optimal cut-off concentrations (expressed as the fold elevation above the respective URL for the assay) and area under the ROC curve (AUROC) for serum gastrin concentrations to distinguish acid-suppressant (H2A and/or PPI)-treated or acid-suppressant-naïve dogs with CE from dogs diagnosed with gastrinoma (n = 14 historical positive controls)

From: Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies

Group comparison

AUROC

Cut-off

Sensitivity

Specificity

all CE dogs vs. gastrinomaa

97%

>1.8 × URL

100%

90%

>3.2 × URL

93%

95%

acid-suppressant-naïve CE dogs vs. gastrinomaa

98%

>1.8 × URL

100%

92%

>3.2 × URL

93%

97%

acid-suppressant-treated CE dogs vs. gastrinomaa

95%

>1.8 × URL

100%

82%

>10.3 × URL

57%

95%

H2A-treated CE dogs vs. gastrinomaa

97%

>1.8 × URL

100%

90%

>3.2 × URL

93%

95%

PPI-treated CE dogs vs. gastrinomaa

91%

>3.2 × URL

93%

77%

>10.3 × URL

57%

95%

  1. AUROC area under the ROC curve, CE chronic enteropathy, H2A histamine type-2 receptor antagonist, PPI proton pump inhibitor, URL upper reference limit
  2. ahistorical positive controls [4, 21,22,23,24,25,26,27,28,29,30]